Home » Authors » Jennifer Boggs

Jennifer Boggs

Articles

ARTICLES

Procyon Cuts Jobs, Closes Labs To Reduce Cash Flow

Jan. 27, 2005

By Jennifer Boggs

ArQule Bringing In $31M For Cancer Drug Development

Jan. 26, 2005

By Jennifer Boggs

Predix Raises $43M Privately To Build Discovery, Clinical Pipeline

Jan. 26, 2005

By Jennifer Boggs

Predix Raises $43M Privately To Build Discovery, Clinical Pipeline

Jan. 26, 2005

By Jennifer Boggs

ArQule Bringing In $31M For Cancer Drug Development

Jan. 26, 2005

By Jennifer Boggs

GTC Is Raising $10M, Aiming For Transgenic Drug Approval

Jan. 25, 2005

By Jennifer Boggs

GTC Is Raising $10M, Aiming For Transgenic Drug Approval

Jan. 25, 2005

By Jennifer Boggs

Chelsea Joins With Ivory Capital, Goes Public Via Reverse Merger

Jan. 24, 2005

By Jennifer Boggs

Chelsea Joins With Ivory Capital, Goes Public Via Reverse Merger

Jan. 24, 2005

By Jennifer Boggs

Having IP, But No Compounds, Sention Signs Deal With Merck

Jan. 21, 2005

By Jennifer Boggs

View All Articles by Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...